SCHEMBL127845

SCHEMBL127845

CCCCCCCCOCC(C)CCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.52
HTT P42858 2/20 0.50
SPHK1 Q9NYA1 1/20 0.50
PLA2G2C Q5R387 2/20 0.46
EPHX2 P34913 1/20 0.45
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKD1 Q15139 1/20 0.44
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27657029 1.00 USP2 (0.52) USP2HTTSPHK1PLA2G2CEPHX2
SCHEMBL5180265 1.00 USP2 (0.52) USP2HTTSPHK1PLA2G2CEPHX2
SCHEMBL18110421 0.91 USP2 (0.52) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL27693785 0.91 USP2 (0.52) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL26803302 0.89 USP2 (0.57) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL25865620 0.89 USP2 (0.57) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL8955582 0.86 USP2 (0.47) USP2HTTSPHK1PLA2G2CEPHX2
SCHEMBL23851234 0.84 USP2 (0.53) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL18019302 0.84 USP2 (0.53) USP2HTTSPHK1PLA2G2CPRKD3
SCHEMBL28848149 0.84 USP2 (0.53) USP2HTTSPHK1PLA2G2CPRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 923 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545585-B2 Method of making carbon nanotube bundles KING ABDULAZIZ UNIVERSITY (SA) 2026-02-10 US claimed
US-20240383756-A1 METHOD OF MAKING CARBON NANOTUBE BUNDLES KING ABDULAZIZ UNIVERSITY (SA) 2024-11-21 US claimed
EP-4203902-B1 HAIR CARE COMPOSITION WITH A ANTIDANDRUFF EFFECT HENKEL AG & CO KGAA (DE) 2026-03-11 EP disclosed
US-12545585-B2 Method of making carbon nanotube bundles KING ABDULAZIZ UNIVERSITY (SA) 2026-02-10 US disclosed
EP-4683610-A1 CATECHOL DERIVATIVES FOR TREATMENT OF SIGNS OF HAIR AGING AND/OR SCALP AGING Henkel AG & Co. KGaA (DE) 2026-01-28 EP disclosed
WO-2025214662-A1 HAIR CARE SHAMPOO CONTAINING POLYLYSINE HENKEL AG & CO. KGAA (DE) 2025-10-16 WO disclosed
WO-2025056266-A1 METHOD FOR REPAIRING HAIR DAMAGE AND FOR STRENGTHENING INNER HAIR STRUCTURE HENKEL AG & CO. KGAA (DE) 2025-03-20 WO disclosed
EP-4504135-A1 HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION Henkel AG & Co. KGaA (DE) 2025-02-12 EP disclosed
EP-4504133-A1 ANTIDANDRUFF SHAMPOO Henkel AG & Co. KGaA (DE) 2025-02-12 EP disclosed
EP-3082959-B2 COSMETIC HAIR CLEANSING COMPOSITION HENKEL AG & CO KGAA (DE) 2024-12-04 EP disclosed
EP-4469017-A1 PROCESS FOR TREATING KERATINOUS MATERIAL, COMPRISING THE MIXING OF AT LEAST TWO AGENTS (A) AND (B) Henkel AG & Co. KGaA (DE) 2024-12-04 EP disclosed
WO-1999058099-A2 METHOD FOR PERMANENTLY SHAPING KERATIN FIBRES, AND AGENTS HANS SCHWARZKOPF GMBH & CO. KG (DE) 1999-11-18 WO disclosed
WO-1999044564-A2 AGENT AND METHOD FOR TREATING KERATINOUS FIBRES HANS SCHWARZKOPF GMBH & CO. KG (DE) 1999-09-10 WO disclosed
WO-1999033435-A1 USE OF TRANSITIONAL METAL COMPLEXES FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-07-08 WO disclosed
WO-1999027900-A1 USE OF POLYETHYLENE IMINES FOR IMPROVING THE MECHANICAL PROPERTIES OF KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-06-10 WO disclosed
WO-1999026592-A1 SPLIT END REGENERATING HAIR TREATMENT AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-06-03 WO disclosed
WO-1999020231-A2 THE USE OF SUBSTITUTED α-NAPHTHOLS FOR DYEING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-29 WO disclosed
WO-1999020597-A1 NOVEL AMINOPHENOL DERIVATIVES AND THE USE THEREOF FOR DYEING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-29 WO disclosed
WO-1999015145-A1 EXTRACT AND COSMETIC PREPARATION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-01 WO disclosed
EP-0786250-A1 Composition for reviving hair Henkel Kommanditgesellschaft auf Aktien (DE) 1997-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545585-B2 Method of making carbon nanotube bundles SDC1, CNTN1, SDC2 USP2 2148/4885HTT 1107/4885SPHK1 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.